KENLIFABI
Live / Allowed — Published for opposition (as of 10 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99360014
- Mark type
- Stylized text
- Filed
- 27 Aug 2025
- Published for opposition
- 10 Feb 2026
- Attorney of record
- Gail I. Nevius Abbas
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, for the treatment of glycolipid storage disorders, and for the treatment of cancer
Owner
- Idorsia Pharmaceuticals Ltd, Allschwil, CH
- Idorsia Pharmaceuticals Ltd, Allschwil, CH
Prosecution history
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jan 2026 — ASSIGNED TO EXAMINER
- 27 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Aug 2025 — NEW APPLICATION ENTERED